Change in 21-gene Recurrence Score result after exposure to neo-adjuvant endocrine therapy in patients with operable breast cancer

Talal Hilal, Lanyu Mi, Natalie M. Ertz-Archambault, Daniel R. Almquist, Karen S. Anderson, Richard J. Gray, Barbara A. Pockaj, Donald W. Northfelt

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
JournalBreast Journal
DOIs
StateAccepted/In press - Jan 1 2019
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine
  • Surgery
  • Oncology

Cite this

Hilal, T., Mi, L., Ertz-Archambault, N. M., Almquist, D. R., Anderson, K. S., Gray, R. J., Pockaj, B. A., & Northfelt, D. W. (Accepted/In press). Change in 21-gene Recurrence Score result after exposure to neo-adjuvant endocrine therapy in patients with operable breast cancer. Breast Journal. https://doi.org/10.1111/tbj.13731